Constitutive activation of the PI3K-Akt pathway in HCC might induce PD-L1 expression, even in a non-inflamed background, where a lack of CD8+ T-cells could be an obstacle for sufficient action of anti-PD-1/PD-L1 monotherapy. The gene discussed is AKT1; the disease is hepatocellular carcinoma.